NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 822.10
-17.80 (-2.12%)
At close: Feb 13, 2026
NATCO Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 18,854 | 13,883 | 7,153 | 1,700 | 4,409 |
Depreciation & Amortization | 1,812 | 1,822 | 1,592 | 1,394 | 1,145 |
Other Amortization | 40 | 46 | 46 | 32 | 24 |
Loss (Gain) From Sale of Assets | -901 | 17 | -178 | -427 | -320 |
Asset Writedown & Restructuring Costs | 530 | - | 23 | - | - |
Loss (Gain) From Sale of Investments | -14 | 7 | 52 | -12 | - |
Stock-Based Compensation | - | - | - | 22 | 126 |
Provision & Write-off of Bad Debts | -11 | 278 | -131 | 470 | 93 |
Other Operating Activities | -1,345 | -843 | -693 | -400 | -360 |
Change in Accounts Receivable | -593 | -3,413 | -2,223 | -2,389 | 1,306 |
Change in Inventory | -653 | 424 | 191 | 564 | -2,402 |
Change in Accounts Payable | 403 | -281 | 1,020 | 74 | -1,095 |
Change in Other Net Operating Assets | -1,154 | 176 | 1,639 | -563 | 62 |
Operating Cash Flow | 16,968 | 12,116 | 8,491 | 465 | 2,988 |
Operating Cash Flow Growth | 40.05% | 42.69% | 1726.02% | -84.44% | -28.40% |
Capital Expenditures | -4,011 | -3,394 | -1,463 | -2,328 | -2,546 |
Sale of Property, Plant & Equipment | 950 | 20 | 305 | 538 | 451 |
Cash Acquisitions | - | - | - | -1,031 | - |
Sale (Purchase) of Intangibles | -904 | -193 | -593 | -99 | 23 |
Investment in Securities | -11,046 | -6,035 | -4,275 | 2,039 | -3,889 |
Other Investing Activities | 870 | -737 | 1,255 | 824 | 4,922 |
Investing Cash Flow | -14,145 | -10,327 | -4,771 | -53 | -1,033 |
Short-Term Debt Issued | - | 1,978 | - | 1,382 | - |
Total Debt Issued | - | 1,978 | - | 1,382 | - |
Short-Term Debt Repaid | -892 | - | -2,390 | - | -484 |
Long-Term Debt Repaid | -34 | -21 | -20 | -24 | -12 |
Total Debt Repaid | -926 | -21 | -2,410 | -24 | -496 |
Net Debt Issued (Repaid) | -926 | 1,957 | -2,410 | 1,358 | -496 |
Issuance of Common Stock | - | - | - | - | 1 |
Repurchase of Common Stock | - | -2,537 | -74 | - | - |
Common Dividends Paid | -1,078 | -1,708 | -1,004 | -822 | -1,139 |
Other Financing Activities | -103 | -181 | -142 | -188 | -223 |
Financing Cash Flow | -2,107 | -2,469 | -3,630 | 348 | -1,857 |
Foreign Exchange Rate Adjustments | -220 | 65 | 118 | 93 | -38 |
Net Cash Flow | 496 | -615 | 208 | 853 | 60 |
Free Cash Flow | 12,957 | 8,722 | 7,028 | -1,863 | 442 |
Free Cash Flow Growth | 48.55% | 24.10% | - | - | -28.25% |
Free Cash Flow Margin | 29.24% | 21.79% | 25.95% | -9.57% | 2.15% |
Free Cash Flow Per Share | 72.34 | 48.59 | 38.50 | -10.21 | 2.42 |
Cash Interest Paid | 176 | 181 | 142 | 170 | 128 |
Cash Income Tax Paid | 3,726 | 2,863 | 1,775 | 482 | 1,300 |
Levered Free Cash Flow | 8,409 | 4,610 | 1,964 | -1,849 | -385 |
Unlevered Free Cash Flow | 8,515 | 4,685 | 2,056 | -1,767 | -326.88 |
Change in Working Capital | -1,997 | -3,094 | 627 | -2,314 | -2,129 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.